Main Conference Day 3
Main Conference Day 3
Plenary Session
8:15am - 8:40am25 mins
Plenary Sessions
Registration and Coffee
8:40am - 8:45am5 mins
Plenary Sessions
Chairperson’s Remarks: Plenary Day 3
8:45am - 9:15am30 mins
Plenary Sessions
Surface Avidity Optimization Drives Potent CAR-T Generation with Targeted LNPs
- Hiroshi Yamada, PhD - Head of Drug Delivery Research and Development, Nitto Denko Corporation
9:15am - 9:45am30 mins
Plenary Sessions
FORCE Platform Enables TfR1-mediated Delivery of Therapeutics for Rare Neuromuscular Diseases
- Stefano Zanotti, PhD - VP, Head of Neuromuscular Research, Dyne Therapeutics
9:45am - 10:15am30 mins
Plenary Sessions
Regulatory CMC Challenges and Strategies for Oligonucleotide and Peptide Programs under Accelerated Review
- David Lin, PhD - President and Principal Consultant, TS Pharma Experts LLC
10:15am - 10:55am40 mins
Plenary Sessions
Networking Refreshment Break with Poster and Exhibit Viewing
Concurrent Conference Tracks
10:55am - 11:00am5 mins
Oligonucleotide Track
Chairperson’s Remarks: Track 1
10:55am - 11:00am5 mins
Peptide Track
Chairperson’s Remarks: Track 2
- El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
11:00am - 11:30am30 mins
Oligonucleotide Track
Extending Oligonucleotide Delivery and Gene Knockdown to Specific Cell Types in Kidney
- Alfica Sehgal, PhD - Chief Scientific Officer, Judo Bio
11:00am - 11:30am30 mins
Peptide Track
PolyPeptide Key Technology Enablers to Speed Up IND and Early Clinical Trials
- Fabien Rousset, PhD - Global Director of Innovation, Polypeptide Group
11:30am - 12:00pm30 mins
Oligonucleotide Track
Expanding RNA Editing Applications to CNS Disorders Through AIMer Chemistry Design
- Chikdu Shivalila, PhD - Senior Scientist, Biology, Wave Life Sciences
11:30am - 12:00pm30 mins
Peptide Track
Greener, Smarter Peptide Manufacturing: Advancing Sustainability and Quality
- Anubrato Aich - Senior Project Manager, AmbioPharm
12:00pm - 12:30pm30 mins
Oligonucleotide Track
Leveraging IGF1R Receptor for Antisense Delivery
- Hien Zhao, PhD - Vice President, Neuroscience Research, Ionis Pharmaceuticals
12:00pm - 12:30pm30 mins
Peptide Track
Driving Further Evolution in Peptide API Downstream Processing
- Yuta Hiroyama - Senior Scientist, Process Chemistry Group, R&D Department, PeptiStar
12:30pm - 1:40pm70 mins
Oligonucleotide Track
Networking Luncheon with Poster and Exhibit Viewing
12:30pm - 1:40pm70 mins
Peptide Track
Networking Luncheon with Poster and Exhibit Viewing
1:40pm - 1:45pm5 mins
Oligonucleotide Track
Chairperson's Remarks: Track 1
1:40pm - 1:45pm5 mins
Peptide Track
Chairperson’s Remarks: Track 2
- El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
1:45pm - 2:15pm30 mins
Oligonucleotide Track
Precision-Engineered SNPD-siRNAs for Allele-Specific Silencing of Disease-Causing Mutations
- Kumiko Ui-Tei, PhD - CTO, ANRis Therapeutics and Director/Professor NucleoTIDE & PepTIDE Drug Discovery Center, Institute of Science Tokyo
1:45pm - 2:15pm30 mins
Peptide Track
Advancing Mid-sized Drug Discovery through Scalable Unnatural Amino Acid Technologies
- Manabu Wadamoto, PhD - Chief Scientist, Chugai Pharmaceutical Co., Ltd.
2:15pm - 2:45pm30 mins
Oligonucleotide Track
Advancing RNA Therapeutics: Preclinical Translation of Antibody Oligonucleotide Conjugates (AOC)
- Husam Younis, PhD - Senior Vice President, Development Science, Avidity Biosciences
2:15pm - 2:45pm30 mins
Peptide Track
Antibody-inducing Peptide Using Universal Epitopes: Concept and Clinical Update
- Hideki Tomioka, PhD - Director of the Board and CSO, FunPep Co., Ltd.
2:45pm - 3:15pm30 mins
Oligonucleotide Track
LC-HRMS Bioanalytical Strategies for Characterizing and Quantifying Antibody-Oligonucleotide Conjugate (AOC) Therapeutics
- Xin Zhang, PhD - Principal Scientist, Denali Therapeutics
2:45pm - 3:15pm30 mins
Peptide Track
A Bioproduction Platform to Generate Functionalized Disulfide-constrained Peptide Analogues
- Sunhee Hwang, PhD - Scientist 4, Genentech
3:15pm - 3:45pm30 mins
Oligonucleotide Track
Networking Refreshment Break with Poster and Exhibit Viewing
3:15pm - 3:45pm30 mins
Peptide Track
Networking Refreshment Break with Poster and Exhibit Viewing
3:45pm - 4:15pm30 mins
Oligonucleotide Track
The Analytical Method Development Challenges of a Peptide PMO Conjugate, VP-001 for the Treatment of Retinitis Pigmentosa RP-11
- Mark Anastasas - Group Lead Chemistry-QC, PYC Therapeutics
3:45pm - 4:15pm30 mins
Peptide Track
Late Breaking Presentation
4:15pm - 4:45pm30 mins
Oligonucleotide Track
Optimizing Oligo Protein Conjugates with Chemistry-Driven Solutions for Enhanced Properties and Scale-Up
- Naresh Jain, PhD - CEO, NJ Bio
4:15pm - 4:45pm30 mins
Peptide Track
Late Breaking Presentation
4:45pm - 5:15pm30 mins
Oligonucleotide Track
Precise Engineering and Structural Elucidation of Aptamer-Drug Conjugates (ApDC) for Implantable Triple-Negative Breast Cancer (TNBC) Therapy
- Jung Hwan Lee, PhD - CEO, Interoligo Corp.
4:45pm - 5:15pm30 mins
Peptide Track
Late Breaking Presentation
5:15pm - 5:20pm5 mins
Oligonucleotide Track
Close of Conference
5:15pm - 5:20pm5 mins
Peptide Track
Close of Conference
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。